Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay

Eitemau Tebyg

• Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface
  gan: Liang, Julia, et al.
  Cyhoeddwyd: (2020)
• Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex
  gan: Liang, Julia, et al.
  Cyhoeddwyd: (2020)
• Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay
  gan: Pitsillou, Eleni, et al.
  Cyhoeddwyd: (2021)
• Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay
  gan: Pitsillou, Eleni, et al.
  Cyhoeddwyd: (2020)
• Inhibition of interferon-stimulated gene 15 and lysine 48-linked ubiquitin binding to the SARS-CoV-2 papain-like protease by small molecules: In silico studies
  gan: Pitsillou, Eleni, et al.
  Cyhoeddwyd: (2021)